{"title":"A Review on the Advancements in COVID-19 Treatments and Vaccines Development","authors":"Duaa Aslam Chaudhry, Kainat Waqar","doi":"10.31703/giidr.2020(v-i).02","DOIUrl":null,"url":null,"abstract":"The outbreak of the COVID-19 pandemic that is caused by novel SARS-CoV-2 has taken the life of millions of people around the globe and has put a challenge on the whole world for identifying and developing the best possible therapies for preventing and treating this deadly infection. Clinical study and health policy and clinical interventions are required for advancements in the effective and safe treatment and prevention of COVID-19 disease. Many drugs have been tested in clinical trials for their effectiveness and safety against COVID-19. Among them, some have shown promising effects like remdesivir, the only COVID-19 drug approved by FDA till now, dexamethasone, monoclonal antibodies, etc. Biological agents have also been shown to be effective against the virus, such as tocilizumab, convalescent plasma, and interferon. The most effective medical intervention for COVID-19 is a vaccination which is currently in a development phase at a rapid pace. However, two vaccines have been authorized by the FDA and a number of vaccines are in their final clinical phase. This paper will analyze all the current advancements within the treatment against the COVID-19.","PeriodicalId":369025,"journal":{"name":"Global Immunological & Infectious Diseases Review","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Immunological & Infectious Diseases Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31703/giidr.2020(v-i).02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The outbreak of the COVID-19 pandemic that is caused by novel SARS-CoV-2 has taken the life of millions of people around the globe and has put a challenge on the whole world for identifying and developing the best possible therapies for preventing and treating this deadly infection. Clinical study and health policy and clinical interventions are required for advancements in the effective and safe treatment and prevention of COVID-19 disease. Many drugs have been tested in clinical trials for their effectiveness and safety against COVID-19. Among them, some have shown promising effects like remdesivir, the only COVID-19 drug approved by FDA till now, dexamethasone, monoclonal antibodies, etc. Biological agents have also been shown to be effective against the virus, such as tocilizumab, convalescent plasma, and interferon. The most effective medical intervention for COVID-19 is a vaccination which is currently in a development phase at a rapid pace. However, two vaccines have been authorized by the FDA and a number of vaccines are in their final clinical phase. This paper will analyze all the current advancements within the treatment against the COVID-19.